World

Anti-drug trafficking committees develop comprehensive plans to combat drug smuggling, trafficking

Jul 06, 2025

New York [US], July 6: The Anti-Drug Trafficking and Anti-Smuggling Committees of the Anti-Drug Council held a coordination meeting to discuss ways to counter the attempts of drug smuggling and trafficking gangs. They also studied the methods used by these cross-border gangs, their smuggling plans and concealment methods, potential alternative methods used by these gangs, and their impact on regional stability.
The attendees reviewed the country's land, air, and sea transportation activities, guarantees for their stability and growth, and prevention of their exploitation by international drug gangs. Members of the two committees, including directors and officers from the Anti-Drug Trafficking Department, the National Guard Command, and Federal Customs, participated in the meeting.
The attendees also discussed the scenarios that drug smuggling gangs may resort to, as well as the airports, seaports, and primary and alternative border crossings that could potentially be used as launching pads for international drug smuggling gangs targeting the country for their criminal activities.
The two committees agreed to develop an action plan that includes several measures to prevent and thwart attempts to bring and traffic drugs into the country.
This meeting is based on the strategic directions of the Anti-Narcotics Council, the national umbrella for agencies concerned with combating the drug scourge in the country, to enhance the integrated work of law enforcement agencies involved in preventing drug smuggling into the country.
Source: Emirates News Agency

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026